Our findings are supported by a study of Jordan and co-workers, who did not detect any differences in S100B and NSE level in OSA patients and assumed that the structural cerebral brain injury might be too small to produce a detectable serum level increase [27]. The gene discussed is S100B; the disease is obstructive sleep apnea syndrome.